- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Accelerate Diagnostics (NASDAQ:AXDX), Quotes and News Summary
Accelerate Diagnostics (NASDAQ: AXDX)
Earnings
see more| FY 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-12-20 | ||||||
| REV | |||||||
| FY 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-11-09 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Accelerate Diagnostics Questions & Answers
You can purchase shares of Accelerate Diagnostics (NASDAQ: AXDX) through any online brokerage.
Other companies in Accelerate Diagnostics’s space includes: NeuroPace (NASDAQ:NPCE), Second Sight Medical (NASDAQ:EYES), LENSAR (NASDAQ:LNSR), Semler Scientific (NASDAQ:SMLR) and Apollo Endosurgery (NASDAQ:APEN).
The latest price target for Accelerate Diagnostics (NASDAQ: AXDX) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting AXDX to rise to within 12 months (a possible 88.68% upside). 50 analyst firms have reported ratings in the last year.
The stock price for Accelerate Diagnostics (NASDAQ: AXDX) is $2.12 last updated August 12, 2022, 8:00 PM UTC.
The next Accelerate Diagnostics (AXDX) dividend date is projected to be Thursday, September 1, 2022.
Accelerate Diagnostics’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Accelerate Diagnostics.
Accelerate Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.